Throughout the COVID-19 pandemic, patients, researchers, and providers became increasingly familiar with mRNA vaccines, which have unparalleled public health benefits. While mRNA vaccines have been researched for years, the rapid...
Throughout the COVID-19 pandemic, the FDA has played a critical role in addressing public health concerns by encouraging practices to minimize infectious disease spread and expediting approval for...
Over the past several months, parents, patients, and pediatric providers have been drowning in elevated rates of COVID, influenza, and respiratory syncytial virus (RSV) infection — coined the...
COVID vaccines and vaccination campaigns have had unparalleled benefits throughout the COVID-19 pandemic. Many argue that vaccines have been the most effective public health tool against infection....
As the COVID pandemic has progressed, the healthcare industry has seen the virus and the state of the pandemic evolve. Equipped with the available vaccines and treatments, providers and other...
In recent months, patients, parents, and providers have become increasingly aware of the rise in viral infection rates. With the tripledemic — including COVID-19, respiratory syncytial virus...
As more and more providers warn against the tripledemic — including RSV, COVID, and influenza — it is crucial to understand the projections and impacts of these cases. Additionally, an in-depth understanding of the tools and...
The COVID-19 pandemic took the world by storm when it began in January 2020. Densely populated cities took a brutal hit with more significant percentages of infection, hospitalization, and death due to...
While less than ideal, the progression of the COVID-19 pandemic has presented public health officials with data to analyze on vaccine uptake. In a recent research letter published in JAMA Network Open,...
As the COVID-19 pandemic progresses, access and affordability to vaccines have been effective tools for public health professionals. Currently, the federal government covers COVID-19 vaccination...
As with any vaccine, the COVID-19 vaccine led to some common side effects. However, the severity of these side effects varies by individual. In a recent study published in JAMA Network Open,...
On August 31, 2022, the FDA approved Moderna and Pfizer Bivalent COVID boosters to replace the previously available monovalent boosters. Since then, the CDC and other public health organizations have...
As the COVID-19 pandemic continues and vaccinations continue to be advanced, many patients are concerned about vaccine side effects. Multiple sources have perpetuated the misconception that COVID-19...
Between 2016 and 2022, the AMA surveyed approximately 1,300 providers in the United States for AMA Digital Health Research. This data collected information on motivations and requirements for digital...
Throughout the COVID-19 pandemic, researchers and clinicians have worked tirelessly to develop new antiviral therapies to prevent, treat, and minimize the effects of the SARS-CoV-2 viral infection....
As new COVID boosters are approved and distributed, understanding how they affect pregnant and lactating individuals will impact public health policies, educational efforts, and provider distribution....
A study published on September 1st in the New England Journal of Medicine tracking health data from 109,254 Israeli adults found a 73% reduction in hospitalization and a 79% reduction in COVID-19...
The FDA’s Report on The State of Pharmaceutical Quality is published annually to analyze quality measures related to drug manufacturers and products. The report looked at manufacturing site...
As the COVID pandemic progresses and new variants appear, clinicians and public health professionals have been concerned about the level of vaccine protection for new variants and subvariants. To...
As the COVID pandemic progresses and infection rates fluctuate, public health officials and organizations seek to provide more options to protect against illness. On August 19, Novavax announced that...
